Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xavier Delavenne

Showing results (11-20 of 104) with videos related to

Pageof 11
Sort By:
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|December 28, 2010
HPLC MS/MS method for quantification of meprobamate in human plasma: application to 24/7 clinical toxicologyXavier Delavenne, Jean Pierre Gay-Montchamp, Thierry Basset
Journal of Thrombosis and Haemostasis : JTH|March 1, 2020
Direct oral anticoagulants: Still too early for prime time after pulmonary endarteriectomy?Laurent Bertoletti, Xavier Jaïs, Souad Bezzeghoud, et al.
Journal of Pharmaceutical and Biomedical Analysis|October 15, 2011
UPLC MS/MS assay for routine quantification of dabigatran - a direct thrombin inhibitor - in human plasmaXavier Delavenne, Julie Moracchini, Silvy Laporte, et al.
Toxicology and Applied Pharmacology|August 19, 2021
Functional, proteomic and phenotypic in vitro studies evidence podocyte injury after chronic exposure to heparinOlivier Delézay, Sophie Hodin, Zhiguo Hé, et al.
European Journal of Drug Metabolism and Pharmacokinetics|December 22, 2021
In Vitro Evaluation of P-gp-Mediated Drug-Drug Interactions Using the RPTEC/TERT1 Human Renal Cell ModelSonia Saib, Sophie Hodin, Valérie Bin, et al.
Journal of Pharmaceutical and Biomedical Analysis|January 14, 2014
Quantification of total and unbound tranexamic acid in human plasma by ultrafiltration liquid chromatography/tandem mass spectrometry: application to pharmacokinetic analysisXavier Delavenne, Adeline Montbel, Sophie Hodin, et al.
Molecular Pharmaceutics|May 1, 2018
Pharmacological Characterization of the RPMI 2650 Model as a Relevant Tool for Assessing the Permeability of Intranasal DrugsClément Mercier, Sophie Hodin, Zhiguo He, et al.
Fundamental & Clinical Pharmacology|November 13, 2020
Is the human model RPTEC/TERT1 a relevant model for assessing renal drug efflux?Sonia Saib, Sophie Hodin, Zhiguo He, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|October 13, 2010
UPLC MS/MS method for quantification of mycophenolic acid and metabolites in human plasma: Application to pharmacokinetic studyXavier Delavenne, Ludivine Juthier, Bertrand Pons, et al.
British Journal of Clinical Pharmacology|December 2, 2017
Is tranexamic acid exposure related to blood loss in hip arthroplasty? A pharmacokinetic-pharmacodynamic studyJulien Lanoiselée, Paul J Zufferey, Edouard Ollier, et al.
Pageof 11

Showing results (11-20 of 104) with videos related to

Sort By:
Pageof 11
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|December 28, 2010
HPLC MS/MS method for quantification of meprobamate in human plasma: application to 24/7 clinical toxicologyXavier Delavenne, Jean Pierre Gay-Montchamp, Thierry Basset
Journal of Thrombosis and Haemostasis : JTH|March 1, 2020
Direct oral anticoagulants: Still too early for prime time after pulmonary endarteriectomy?Laurent Bertoletti, Xavier Jaïs, Souad Bezzeghoud, et al.
Journal of Pharmaceutical and Biomedical Analysis|October 15, 2011
UPLC MS/MS assay for routine quantification of dabigatran - a direct thrombin inhibitor - in human plasmaXavier Delavenne, Julie Moracchini, Silvy Laporte, et al.
Toxicology and Applied Pharmacology|August 19, 2021
Functional, proteomic and phenotypic in vitro studies evidence podocyte injury after chronic exposure to heparinOlivier Delézay, Sophie Hodin, Zhiguo Hé, et al.
European Journal of Drug Metabolism and Pharmacokinetics|December 22, 2021
In Vitro Evaluation of P-gp-Mediated Drug-Drug Interactions Using the RPTEC/TERT1 Human Renal Cell ModelSonia Saib, Sophie Hodin, Valérie Bin, et al.
Journal of Pharmaceutical and Biomedical Analysis|January 14, 2014
Quantification of total and unbound tranexamic acid in human plasma by ultrafiltration liquid chromatography/tandem mass spectrometry: application to pharmacokinetic analysisXavier Delavenne, Adeline Montbel, Sophie Hodin, et al.
Molecular Pharmaceutics|May 1, 2018
Pharmacological Characterization of the RPMI 2650 Model as a Relevant Tool for Assessing the Permeability of Intranasal DrugsClément Mercier, Sophie Hodin, Zhiguo He, et al.
Fundamental & Clinical Pharmacology|November 13, 2020
Is the human model RPTEC/TERT1 a relevant model for assessing renal drug efflux?Sonia Saib, Sophie Hodin, Zhiguo He, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|October 13, 2010
UPLC MS/MS method for quantification of mycophenolic acid and metabolites in human plasma: Application to pharmacokinetic studyXavier Delavenne, Ludivine Juthier, Bertrand Pons, et al.
British Journal of Clinical Pharmacology|December 2, 2017
Is tranexamic acid exposure related to blood loss in hip arthroplasty? A pharmacokinetic-pharmacodynamic studyJulien Lanoiselée, Paul J Zufferey, Edouard Ollier, et al.
Pageof 11